Biologics Distributor for Salem, Oregon Medspas and Dermatology Clinics

How medspas and dermatology practices evaluate a new supplier

Medspas operating under physician supervision and dermatology practices in the Salem area generally assign vendor review to the supervising physician or practice manager, checking that any new biologics line is documented at the lot level and that the supplier's regulatory framing matches the product category: Wharton's jelly allograft versus exosome product.

Because exosome products are not FDA-approved and are generally regulated as biologic drugs, many practices ask their medical director to confirm the intended use with counsel before the first order.

Lot documentation for aesthetic and dermatology accounts

Each lot shipped carries a unique identifier. A certificate of analysis, donor eligibility summary, and lot release record are available on request, which gives a medspa or dermatology practice a documented basis for each product it stocks rather than relying on marketing claims.

Full ingredient disclosures for lyophilized exosome formats are shared with verified accounts so a practice can review composition before ordering.

NPI-verified ordering

Accounts are opened only for licensed professionals and require an NPI number at setup. A medspa supervised by a physician typically ties the account to the supervising physician's NPI, with front-desk or practice-manager staff added as ordering contacts.

Pricing is not published online and is shared directly with the verified account once setup is complete.

Receiving shipments and getting started

Cryopreserved Wharton's jelly products ship overnight on dry ice in validated containers and move into -80 degree C storage on arrival; lyophilized exosome products are shelf-stable and ship without cold-chain requirements. A Salem practice ordering both formats should plan separate receiving steps for each.

Before placing a first order, confirm your intended use and supervision requirements with the Oregon Medical Board and your own counsel. Precision Biologics can walk a new account through NPI verification and first-shipment logistics by phone.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.